A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

ConditionFabry Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

AgeNot listed

SponsorAmicus Therapeutics

About this trial

This is a global prospective observational study of women with Fabry disease and their infants during pregnancy and/or breastfeeding. The study will evaluate outcomes of pregnancy and/or breastfeeding in women and infants exposed to migalastat.

Eligibility criteria

Qualifiers

Patients with Fabry disease who are pregnant and/or breastfeeding, whether or not they are exposed to migalastat

Able and willing to provide informed consent or assent, if applicable.

Able and willing to provide HCP contact information.

Disqualifiers

None

Trial design

Treatments tested in this trial

migalastat

Treatment groups

20 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Amicus Therapeutics

Lead sponsor

Source ClinicalTrials.gov